JPMorgan Chase & Co’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.68M Buy
191,613
+3,210
+2% +$44.9K ﹤0.01% 3145
2025
Q1
$2.56M Sell
188,403
-34,580
-16% -$470K ﹤0.01% 3106
2024
Q4
$4.54M Sell
222,983
-12,403
-5% -$253K ﹤0.01% 2830
2024
Q3
$6.86M Buy
235,386
+14,324
+6% +$417K ﹤0.01% 2426
2024
Q2
$5.13M Buy
221,062
+82,122
+59% +$1.91M ﹤0.01% 2515
2024
Q1
$2.85M Sell
138,940
-44,376
-24% -$911K ﹤0.01% 2917
2023
Q4
$3.93M Buy
183,316
+15,352
+9% +$329K ﹤0.01% 2712
2023
Q3
$3.47M Buy
167,964
+9,972
+6% +$206K ﹤0.01% 2650
2023
Q2
$4.66M Buy
157,992
+12,005
+8% +$354K ﹤0.01% 2539
2023
Q1
$3.36M Sell
145,987
-37,989
-21% -$875K ﹤0.01% 2707
2022
Q4
$5.12M Buy
183,976
+75,622
+70% +$2.1M ﹤0.01% 2353
2022
Q3
$3.33M Buy
108,354
+8,329
+8% +$256K ﹤0.01% 2604
2022
Q2
$2.94M Buy
100,025
+2,653
+3% +$78.1K ﹤0.01% 2763
2022
Q1
$3.13M Buy
97,372
+14,227
+17% +$458K ﹤0.01% 2883
2021
Q4
$3.71M Sell
83,145
-15,365
-16% -$685K ﹤0.01% 2781
2021
Q3
$4.97M Buy
98,510
+7,630
+8% +$385K ﹤0.01% 2581
2021
Q2
$7.13M Buy
90,880
+15,699
+21% +$1.23M ﹤0.01% 2399
2021
Q1
$4.29M Sell
75,181
-255,912
-77% -$14.6M ﹤0.01% 2747
2020
Q4
$27.7M Buy
331,093
+22,239
+7% +$1.86M ﹤0.01% 1248
2020
Q3
$11.2M Buy
308,854
+64,168
+26% +$2.33M ﹤0.01% 1706
2020
Q2
$5.92M Buy
244,686
+68,843
+39% +$1.66M ﹤0.01% 2057
2020
Q1
$3.08M Buy
175,843
+98,101
+126% +$1.72M ﹤0.01% 2325
2019
Q4
$1.35M Buy
77,742
+62,023
+395% +$1.08M ﹤0.01% 2900
2019
Q3
$241K Buy
15,719
+2,549
+19% +$39.1K ﹤0.01% 3665
2019
Q2
$271K Buy
13,170
+2,101
+19% +$43.2K ﹤0.01% 3645
2019
Q1
$257K Sell
11,069
-571
-5% -$13.3K ﹤0.01% 3658
2018
Q4
$240K Buy
11,640
+1,086
+10% +$22.4K ﹤0.01% 3721
2018
Q3
$229K Buy
10,554
+7,120
+207% +$154K ﹤0.01% 3821
2018
Q2
$52K Buy
3,434
+184
+6% +$2.79K ﹤0.01% 4298
2018
Q1
$64K Buy
+3,250
New +$64K ﹤0.01% 4068